Senseonics Holdings (SENS) Misses Q2 EPS by 9c, Revenues Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. MRK
7. LVS
8. SAP
9. CSX
10. LRCX

Go back to Senseonics Holdings (SENS) Misses Q2 EPS by 9c, Revenues Miss

Senseonics Holdings, Inc. Reports Second Quarter 2018 Financial Results

August 8, 2018 4:10 PM EDT

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE-American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the second quarter ended June 30, 2018.

RECENT HIGHLIGHTS & ACCOMPLISHMENTS:

Received FDA approval for the Eversense® CGM System, the first and only long-term implantable continuous glucose monitoring system Completed first commercial insertion in the U.S. Secured first U.S. payor coverage of Eversense from Horizon... More